通过国家卫生数据系统诊断自闭症的流行率。2010 - 2022年回顾性队列分析

Q4 Medicine

Neuropsychiatrie de l''Enfance et de l''Adolescence Pub Date : 2025-09-01 DOI:10.1016/j.neurenf.2025.01.006

Sébastien Ponnou , Xavier Briffault , Victor Aragno , Benoît Thomé , Brigitte Chamak

{"title":"通过国家卫生数据系统诊断自闭症的流行率。2010 - 2022年回顾性队列分析","authors":"Sébastien Ponnou , Xavier Briffault , Victor Aragno , Benoît Thomé , Brigitte Chamak","doi":"10.1016/j.neurenf.2025.01.006","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>Autism is considered a major public health issue in France and internationally. In contrast to other countries, where multiple epidemiological studies have been carried out for many years, scientific data on the prevalence of autism in France remains scarce. This article aims to provide reliable figures by way of the National Health Data System (SNDS) and to update the currently available epidemiological studies.</div></div><div><h3>Method and results</h3><div>The prevalence of autism via the SNDS was 0.1% in 2010, rising to 0.2% in 2022. It was four times higher among males than females. The prevalence of autism via the SNDS was significantly higher in children and decreased with age. Among children aged 8, it doubled between 2010 and 2022, rising from 0.45 to 0.94%. More specifically, this prevalence of autism via the SNDS rose from 0.7 to 1.5% for 8-year-old boys and from 0.2 to 0.4% for girls. Among children aged 0 to 10, the diagnosis peak was at age 3, with a steep rise between ages 1 and 3. Between 2010 and 2022, the proportion of autistic patients aged 0 to 17 living in unfavorable social conditions rose from 29 to 42.4%.</div></div><div><h3>Conclusion</h3><div>Estimating the prevalence of autism is essential for informing public authorities and adapting the needs of care, education and social intervention services. Epidemiological research on autism and the data contained in the SNDS contribute to this effort aimed at assisting patients and their families.</div></div>","PeriodicalId":39666,"journal":{"name":"Neuropsychiatrie de l''Enfance et de l''Adolescence","volume":"73 5","pages":"Pages 276-288"},"PeriodicalIF":0.0000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Prévalence des diagnostics d’autisme via le système national de données de santé. Analyse rétrospective de cohorte sur la période 2010–2022\",\"authors\":\"Sébastien Ponnou , Xavier Briffault , Victor Aragno , Benoît Thomé , Brigitte Chamak\",\"doi\":\"10.1016/j.neurenf.2025.01.006\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><div>Autism is considered a major public health issue in France and internationally. In contrast to other countries, where multiple epidemiological studies have been carried out for many years, scientific data on the prevalence of autism in France remains scarce. This article aims to provide reliable figures by way of the National Health Data System (SNDS) and to update the currently available epidemiological studies.</div></div><div><h3>Method and results</h3><div>The prevalence of autism via the SNDS was 0.1% in 2010, rising to 0.2% in 2022. It was four times higher among males than females. The prevalence of autism via the SNDS was significantly higher in children and decreased with age. Among children aged 8, it doubled between 2010 and 2022, rising from 0.45 to 0.94%. More specifically, this prevalence of autism via the SNDS rose from 0.7 to 1.5% for 8-year-old boys and from 0.2 to 0.4% for girls. Among children aged 0 to 10, the diagnosis peak was at age 3, with a steep rise between ages 1 and 3. Between 2010 and 2022, the proportion of autistic patients aged 0 to 17 living in unfavorable social conditions rose from 29 to 42.4%.</div></div><div><h3>Conclusion</h3><div>Estimating the prevalence of autism is essential for informing public authorities and adapting the needs of care, education and social intervention services. Epidemiological research on autism and the data contained in the SNDS contribute to this effort aimed at assisting patients and their families.</div></div>\",\"PeriodicalId\":39666,\"journal\":{\"name\":\"Neuropsychiatrie de l''Enfance et de l''Adolescence\",\"volume\":\"73 5\",\"pages\":\"Pages 276-288\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neuropsychiatrie de l''Enfance et de l''Adolescence\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0222961725000261\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuropsychiatrie de l''Enfance et de l''Adolescence","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0222961725000261","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

目的自闭症在法国和国际上被认为是一个重大的公共卫生问题。与其他国家多年来开展了多项流行病学研究相比，法国自闭症患病率的科学数据仍然很少。本文旨在通过国家卫生数据系统（SNDS）提供可靠的数据，并更新现有的流行病学研究。方法与结果2010年通过SNDS的自闭症患病率为0.1%，2022年上升至0.2%。男性的自杀率是女性的四倍。通过SNDS的自闭症患病率在儿童中明显较高，并随着年龄的增长而下降。在8岁儿童中，这一比例在2010年至2022年间翻了一番，从0.45%上升到0.94%。更具体地说，通过SNDS的自闭症患病率在8岁男孩中从0.7上升到1.5%，在女孩中从0.2上升到0.4%。在0 - 10岁的儿童中，诊断高峰在3岁，在1 - 3岁之间急剧上升。2010年至2022年间，0 - 17岁自闭症患者生活在不利社会环境中的比例从29%上升到42.4%。结论评估自闭症的患病率对于告知公共当局和适应护理、教育和社会干预服务的需求至关重要。关于自闭症的流行病学研究和SNDS中所载的数据有助于这项旨在帮助患者及其家属的努力。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Prévalence des diagnostics d’autisme via le système national de données de santé. Analyse rétrospective de cohorte sur la période 2010–2022

Objective

Autism is considered a major public health issue in France and internationally. In contrast to other countries, where multiple epidemiological studies have been carried out for many years, scientific data on the prevalence of autism in France remains scarce. This article aims to provide reliable figures by way of the National Health Data System (SNDS) and to update the currently available epidemiological studies.

Method and results

The prevalence of autism via the SNDS was 0.1% in 2010, rising to 0.2% in 2022. It was four times higher among males than females. The prevalence of autism via the SNDS was significantly higher in children and decreased with age. Among children aged 8, it doubled between 2010 and 2022, rising from 0.45 to 0.94%. More specifically, this prevalence of autism via the SNDS rose from 0.7 to 1.5% for 8-year-old boys and from 0.2 to 0.4% for girls. Among children aged 0 to 10, the diagnosis peak was at age 3, with a steep rise between ages 1 and 3. Between 2010 and 2022, the proportion of autistic patients aged 0 to 17 living in unfavorable social conditions rose from 29 to 42.4%.

Conclusion

Estimating the prevalence of autism is essential for informing public authorities and adapting the needs of care, education and social intervention services. Epidemiological research on autism and the data contained in the SNDS contribute to this effort aimed at assisting patients and their families.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Neuropsychiatrie de l''Enfance et de l''Adolescence Medicine-Pediatrics, Perinatology and Child Health

CiteScore

0.60

自引率

0.00%

发文量

期刊介绍： Organ of the Société française de psychiatrie de enfant et de adolescent, Neuropsychiatrie de enfance et de adolescence tackles all fields of child-adolescent psychiatry and offers a link between field and clinical work. As a reference and training tool for students and practitioners, the journal publishes original papers in child psychiatry as well as book reviews and conference reports. Each issue also offers a calendar of the main events dealing with the speciality.